Notify me when Harbert Discovery Fund, LP files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ENZB | ENZO BIOCHEM INC | Common Stock, par value $0.01 per share | 9.9% | $2,898,511 | 5,175,913 | Harbert Fund Advisors, Inc. | 23 Jun 2025 | ||
| TACT | TRANSACT TECHNOLOGIES INC | Common Stock, par value $0.01 per share | 4.3% | $1,633,973 | -$418,388 | 429,993 | -20% | HARBERT DISCOVERY FUND LP | 22 Sep 2025 |
| STRM | STREAMLINE HEALTH SOLUTIONS INC. | Common Stock, $0.01 par value per share | 0% | $0 | -$1,775,970 | 0 | -100% | Harbert Discovery Fund, LP | 12 Aug 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|